F. Sawczak, A. Kukfisz, Maria Cierzniak, Alicja Szubarga, A. Soloch, Anita Balewska, M. Szczechla, H. Krysztofiak, K. Przytarska, M. Dudek, Izabella Uchmanowicz, E. Straburzyńska-Migaj, M. Kałużna-Oleksy
{"title":"Relationship of pre-pandemic quality of life and avoiding vaccination against SARS-CoV-2 in patients with heart failure – a cohort study","authors":"F. Sawczak, A. Kukfisz, Maria Cierzniak, Alicja Szubarga, A. Soloch, Anita Balewska, M. Szczechla, H. Krysztofiak, K. Przytarska, M. Dudek, Izabella Uchmanowicz, E. Straburzyńska-Migaj, M. Kałużna-Oleksy","doi":"10.20883/medical.e883","DOIUrl":null,"url":null,"abstract":"Heart failure (HF) patients are vulnerable to a complicated course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this research was to analyze the relationship between the decision not to be immunized against SARS-CoV-2, clinical, epidemiological factors and pre-pandemic health-related quality of life (HRQoL) of HF patients . Prior to the onset of the SARS-CoV-2 pandemic, hospitalized HF patients were enrolled as a prospective cohort and interviewed with World Health Organization Quality of Life Brief Version questionnaire. On October 30, 2021, the immunization status was verified. The association of vaccination hesitancy with epidemiological and clinical parameters, and pre-pandemic questionnaire results was tested. Subsequently, the independence from confounding factors, age, sex, New York Heart Association (NYHA) scale, and left ventricular ejection fraction (LVEF) was analyzed. Among 136 included patients, 77.9% were vaccinated. Unvaccinated patients were younger (51.2±13.2 vs 56.6±10.3; p=0.018) and more frequently had non-ischemic etiology of HF (73.3% vs. 46.7%; p=0.013). It was significant after adjustment for age, sex, NYHA class and LVEF. There was no association of overall HRQoL or domain scores with vaccination status. Younger age as a factor associated with vaccine avoidance in this population is consistent with data from the general population despite higher exposure to the severe course of the disease.","PeriodicalId":16350,"journal":{"name":"Journal of Medical Science","volume":"36 21","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20883/medical.e883","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Heart failure (HF) patients are vulnerable to a complicated course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The aim of this research was to analyze the relationship between the decision not to be immunized against SARS-CoV-2, clinical, epidemiological factors and pre-pandemic health-related quality of life (HRQoL) of HF patients . Prior to the onset of the SARS-CoV-2 pandemic, hospitalized HF patients were enrolled as a prospective cohort and interviewed with World Health Organization Quality of Life Brief Version questionnaire. On October 30, 2021, the immunization status was verified. The association of vaccination hesitancy with epidemiological and clinical parameters, and pre-pandemic questionnaire results was tested. Subsequently, the independence from confounding factors, age, sex, New York Heart Association (NYHA) scale, and left ventricular ejection fraction (LVEF) was analyzed. Among 136 included patients, 77.9% were vaccinated. Unvaccinated patients were younger (51.2±13.2 vs 56.6±10.3; p=0.018) and more frequently had non-ischemic etiology of HF (73.3% vs. 46.7%; p=0.013). It was significant after adjustment for age, sex, NYHA class and LVEF. There was no association of overall HRQoL or domain scores with vaccination status. Younger age as a factor associated with vaccine avoidance in this population is consistent with data from the general population despite higher exposure to the severe course of the disease.
心力衰竭(HF)患者容易受到复杂的严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)感染。本研究旨在分析不接种SARS-CoV-2疫苗的决定与临床、流行病学因素与HF患者大流行前健康相关生活质量(HRQoL)的关系。在SARS-CoV-2大流行发生之前,将住院的HF患者纳入前瞻性队列,并使用世界卫生组织生活质量简要版问卷进行访谈。2021年10月30日,确认免疫接种情况。对疫苗接种犹豫与流行病学和临床参数以及大流行前问卷调查结果的关系进行了测试。随后,对年龄、性别、纽约心脏协会(NYHA)量表和左室射血分数(LVEF)等混杂因素的独立性进行分析。在136例纳入的患者中,77.9%的人接种了疫苗。未接种疫苗的患者更年轻(51.2±13.2 vs 56.6±10.3;p=0.018),非缺血性病因发生率更高(73.3% vs. 46.7%;p = 0.013)。经年龄、性别、NYHA分级及LVEF校正后,差异有统计学意义。总体HRQoL或域评分与疫苗接种状态没有关联。在这一人群中,较年轻的年龄是与避免接种疫苗相关的一个因素,这与普通人群的数据一致,尽管他们对该病的严重病程的暴露程度较高。